Position in ORGO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,412,220
+$560,538 QoQ
Shares Held
3,050,297
+5.5% QoQ
Ownership
2.37%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 135 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 88%
Shared 7%
None 4%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $3,170,376,127 across 48 Drug Manufacturers - Specialty & Generic names. ORGO ranks #33 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
25,417,271 | $625,519,037 | |
| 2 | VTRS |
Viatris Inc
|
29,970,094 | $475,925,092 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
527,904 | $286,034,221 | |
| 4 | ALKS |
Alkermes plc.
|
4,194,873 | $219,811,343 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
1,466,260 | $162,666,882 | |
| 6 | ZTS |
Zoetis Inc.
|
2,173,278 | $156,171,754 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
2,661,291 | $125,799,224 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
732,877 | $123,519,088 |
All Filings in ORGO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,412,220 | 3,050,297 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,851,682 | 2,891,006 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $14,146,475 | 2,730,980 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,276,939 | 2,909,228 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $11,362,651 | 3,104,550 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,393,709 | 3,100,396 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,925,646 | 2,789,265 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,710,968 | 2,346,493 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,702,879 | 2,036,743 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,838,279 | 1,703,620 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $5,673,400 | 1,387,140 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,723,732 | 856,520 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,378,951 | 415,347 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $970,373 | 455,575 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,411,072 | 525,217 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,382,846 | 735,447 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,943,946 | 808,186 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,414,249 | 185,597 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,668,605 | 180,585 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,920,833 | 134,890 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||